193 related articles for article (PubMed ID: 8495195)
21. Expression of active human C1 inhibitor serpin domain in Escherichia coli.
Lamark T; Ingebrigtsen M; Bjørnstad C; Melkko T; Mollnes TE; Nielsen EW
Protein Expr Purif; 2001 Jul; 22(2):349-58. PubMed ID: 11437612
[TBL] [Abstract][Full Text] [Related]
22. Recombinant hirustasin: production in yeast, crystallization, and interaction with serine proteases.
Di Marco S; Fendrich G; Knecht R; Strauss A; Pohlig G; Heim J; Priestle JP; Sommerhoff CP; Grütter MG
Protein Sci; 1997 Jan; 6(1):109-18. PubMed ID: 9007982
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory property characterization and reactive site exploration of the arrowhead proteinase inhibitor.
Yang HL; Wang LX; Zhu DX; Qi ZW
Sci China B; 1991 Jul; 34(7):832-9. PubMed ID: 1878144
[TBL] [Abstract][Full Text] [Related]
24. Development of a novel recombinant serpin with potential antithrombotic properties.
Hopkins PC; Crowther DC; Carrell RW; Stone SR
J Biol Chem; 1995 May; 270(20):11866-71. PubMed ID: 7744836
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory plant serpins with a sequence of three glutamine residues in the reactive center.
Hejgaard J
Biol Chem; 2005 Dec; 386(12):1319-23. PubMed ID: 16336127
[TBL] [Abstract][Full Text] [Related]
26. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
28. [Identification of a methionine residue as the reactive site for chymotrypsin in the double-headed proteinase inhibitor from the canine submandibular gland (author's transl)].
Hochstrasser K; Fritz H
Hoppe Seylers Z Physiol Chem; 1975 Dec; 356(12):1859-63. PubMed ID: 1213681
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
Czapinska H; Helland R; Smalås AO; Otlewski J
J Mol Biol; 2004 Dec; 344(4):1005-20. PubMed ID: 15544809
[TBL] [Abstract][Full Text] [Related]
30. The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor.
Kim H; Chu TT; Kim DY; Kim DR; Nguyen CM; Choi J; Lee JR; Hahn MJ; Kim KK
J Mol Biol; 2008 Feb; 376(1):184-92. PubMed ID: 18155725
[TBL] [Abstract][Full Text] [Related]
31. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.
Harpel PC; Cooper NR
J Clin Invest; 1975 Mar; 55(3):593-604. PubMed ID: 123251
[TBL] [Abstract][Full Text] [Related]
32. Binding of amino acid side-chains to S1 cavities of serine proteinases.
Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
[TBL] [Abstract][Full Text] [Related]
33. Functional analysis of the serpin domain of C1 inhibitor.
Coutinho M; Aulak KS; Davis AE
J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
[TBL] [Abstract][Full Text] [Related]
34. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
Weiss V; Engel J
Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
Kress LF
J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
[TBL] [Abstract][Full Text] [Related]
36. Reactive sites of the 21-kD protein inhibitor of serine proteinases from potato tubers.
Valueva TA; Revina TA; Mosolov VV
Biochemistry (Mosc); 1999 Sep; 64(9):1074-8. PubMed ID: 10521725
[TBL] [Abstract][Full Text] [Related]
37. Identification of trypsin-inhibitory site and structure determination of human SPINK2 serine proteinase inhibitor.
Chen T; Lee TR; Liang WG; Chang WS; Lyu PC
Proteins; 2009 Oct; 77(1):209-19. PubMed ID: 19422058
[TBL] [Abstract][Full Text] [Related]
38. Redesigning the reactive site loop of the wheat subtilisin/chymotrypsin inhibitor (WSCI) by site-directed mutagenesis. A protein-protein interaction study by affinity chromatography and molecular modeling.
Bruni N; Di Maro A; Costantini S; Chambery A; Facchiano AM; Ficca AG; Parente A; Poerio E
Biochimie; 2009 Sep; 91(9):1112-22. PubMed ID: 19500644
[TBL] [Abstract][Full Text] [Related]
39. Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library.
McBride JD; Freeman N; Domingo GJ; Leatherbarrow RJ
J Mol Biol; 1996 Jun; 259(4):819-27. PubMed ID: 8683585
[TBL] [Abstract][Full Text] [Related]
40. An evolutionarily conserved binding site for serine proteinase inhibitors in large conductance calcium-activated potassium channels.
Moss GW; Marshall J; Morabito M; Howe JR; Moczydlowski E
Biochemistry; 1996 Dec; 35(50):16024-35. PubMed ID: 8973172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
